(Q44823741)

English

GA201 (RG7160): a novel, humanized, glycoengineered anti-EGFR antibody with enhanced ADCC and superior in vivo efficacy compared with cetuximab

scientific article published on 3 December 2012

Statements

GA201 (RG7160): a novel, humanized, glycoengineered anti-EGFR antibody with enhanced ADCC and superior in vivo efficacy compared with cetuximab (English)
Christian A Gerdes
Valeria Gonzalez Nicolini
Erwin van Puijenbroek
Michaela Roemmele
Ekkehard Moessner
Birgit Bossenmaier
Hans Joachim Mueller

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit